These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3400296)

  • 1. [Assessment of prognosis with Markov chains in chronic cardiovascular diseases in relation to various therapies].
    Grimm J; Hempel WE; Gerst H; Richter K; Hempel B
    Z Gesamte Inn Med; 1988 Apr; 43(8):205-9. PubMed ID: 3400296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of various forms of therapy in chronic cardiovascular diseases--a vector analysis of the transition probabilities of degrees of severity].
    Hempel WE; Gerst H; Hempel B; Richter K; Cobet H; Steinbach W
    Z Gesamte Inn Med; 1988 Nov; 43(21):609-13. PubMed ID: 3213124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problem-specific grading in disease course assessment and calculation of the likelihood of transition of chronic cardiovascular diseases].
    Hempel B; Hempel WE; Gerst H; Grimm J; Richter K
    Z Gesamte Inn Med; 1987 Jun; 42(12):329-33. PubMed ID: 3630278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced external counterpulsation--a therapeutic option for patients with chronic cardiovascular problems.
    Linnemeier G
    J Cardiovasc Manag; 2002; 13(6):20-5. PubMed ID: 12500419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term study of angiologic patients with over 15 years of dispensary care with special reference to early manifesting angio-organopathies].
    Runge E
    Z Gesamte Inn Med; 1985 May; 40(9):261-4. PubMed ID: 3925654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value and rank of diagnostic laboratory parameters in cardiovascular diseases. Results of multivariant and discriminant analyses of the Berlin EBMO-Cor population study].
    Gerhard W; Hempel WE; Hermann K; Richter K; Wagenknecht CU
    Z Kardiol; 1987 Jan; 76(1):44-50. PubMed ID: 3564617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of so-called cardiovascular risk factors in general practice cardiac therapy--results of selected biochemical parameters of probands with suspect cardiovascular findings in a follow-up program of a 5-year intervention study].
    Richter K; Hempel WE; Gerhard W; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Nov; 41(21):598-602. PubMed ID: 3825212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and cardiovascular risk assessment in dialysis patients.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M;
    Nephrol Dial Transplant; 2004 May; 19(5):1058-68. PubMed ID: 15004266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Redundancy reduction in laboratory studies--evaluated by the laboratory diagnostic follow-up program of an epidemiologic cardiovascular study].
    Gerhard W; Hempel WE; Richter K; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Jan; 41(2):34-6. PubMed ID: 3953123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP.
    Giannitsis E
    Clin Lab; 2005; 51(1-2):63-83. PubMed ID: 15719708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodology and organization of a laboratory diagnostic study program within the scope of epidemiologic cardiovascular studies exemplified by the Berlin EMBO-Cor research project].
    Gerhard W; Hempel WE; Richter K; Wagenknecht CU
    Z Gesamte Inn Med; 1988 Feb; 43(4):93-5. PubMed ID: 3376507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.
    Samuelsson O
    Acta Med Scand Suppl; 1985; 702():1-79. PubMed ID: 3866485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.